Ningbo David Medical Device Co Ltd Net Assets
Ningbo David Medical Device Co Ltd net assets. Based on the latest financial reports, Ningbo David Medical Device Co Ltd (300314) has net assets worth CN¥1.23 Billion CNY (≈ $180.30 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.47 Billion ≈ $214.74 Million USD) and total liabilities (CN¥235.40 Million ≈ $34.45 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Ningbo David Medical Device Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.23 Billion |
| % of Total Assets | 83.96% |
| Annual Growth Rate | 17.25% |
| 5-Year Change | 24.48% |
| 10-Year Change | 64.72% |
| Growth Volatility | 60.36 |
Net Assets of Ningbo David Medical Device Co Ltd (2008–2025)
Net assets of Ningbo David Medical Device Co Ltd from 2008 to 2025. This chart illustrates how Ningbo David Medical Device Co Ltd's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Ningbo David Medical Device Co Ltd to measure how much of total assets are equity-financed.
Annual Net Assets for Ningbo David Medical Device Co Ltd (2008–2025)
The table below shows the annual net assets of Ningbo David Medical Device Co Ltd from 2008 to 2025. For live market cap and overall valuation, see Ningbo David Medical Device Co Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.23 Billion ≈ $180.42 Million |
+5.53% |
| 2024-12-31 | CN¥1.17 Billion ≈ $170.96 Million |
+0.42% |
| 2023-12-31 | CN¥1.16 Billion ≈ $170.25 Million |
+9.83% |
| 2022-12-31 | CN¥1.06 Billion ≈ $155.01 Million |
+6.94% |
| 2021-12-31 | CN¥990.53 Million ≈ $144.95 Million |
+3.88% |
| 2020-12-31 | CN¥953.52 Million ≈ $139.53 Million |
+15.04% |
| 2019-12-31 | CN¥828.85 Million ≈ $121.29 Million |
+4.56% |
| 2018-12-31 | CN¥792.71 Million ≈ $116.00 Million |
+1.85% |
| 2017-12-31 | CN¥778.30 Million ≈ $113.89 Million |
+3.97% |
| 2016-12-31 | CN¥748.55 Million ≈ $109.54 Million |
+7.26% |
| 2015-12-31 | CN¥697.90 Million ≈ $102.12 Million |
+4.33% |
| 2014-12-31 | CN¥668.97 Million ≈ $97.89 Million |
+6.50% |
| 2013-12-31 | CN¥628.16 Million ≈ $91.92 Million |
+6.09% |
| 2012-12-31 | CN¥592.09 Million ≈ $86.64 Million |
+260.48% |
| 2011-12-31 | CN¥164.25 Million ≈ $24.03 Million |
+48.94% |
| 2010-12-31 | CN¥110.28 Million ≈ $16.14 Million |
+38.60% |
| 2009-12-31 | CN¥79.57 Million ≈ $11.64 Million |
-3.51% |
| 2008-12-31 | CN¥82.46 Million ≈ $12.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ningbo David Medical Device Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2435.0% over the analyzed period, indicating profitable operations and earnings retention.
Ningbo David Medical Device Co Ltd Net Assets Breakdown (December 2025)
Ningbo David Medical Device Co Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥670.59 Million | 54.39% |
| Other Components | CN¥562.38 Million | 45.61% |
| Total Equity | CN¥1.23 Billion | 100.00% |
Ningbo David Medical Device Co Ltd Competitors by Market Cap
The table below lists competitors of Ningbo David Medical Device Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Complete Logistic Services Bhd
KLSE:5136
|
$594.31 Million |
|
Tempo Scan Pacific Tbk
JK:TSPC
|
$594.59 Million |
|
Sichuan Mingxing Electric Power Co Ltd
SHG:600101
|
$594.86 Million |
|
Phenix Optical Co Ltd
SHG:600071
|
$594.97 Million |
|
Shaanxi Construction Machinery Co Ltd
SHG:600984
|
$594.14 Million |
|
Guangdong Sunwill Precising Plastic Co Ltd
SHE:002676
|
$594.04 Million |
|
SILEX Systems Ltd
AU:SLX
|
$593.99 Million |
|
Wecome Pharmaceutical Co Ltd
SHE:300878
|
$593.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ningbo David Medical Device Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,168,317,369 to 1,232,977,162, a change of 64,659,793 (5.5%).
- Net income of 87,053,320 contributed positively to equity growth.
- Dividend payments of 25,056,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥87.05 Million | +7.06% |
| Dividends Paid | CN¥25.06 Million | -2.03% |
| Other Changes | CN¥2.66 Million | +0.22% |
| Total Change | CN¥- | 5.53% |
Book Value vs Market Value Analysis
This analysis compares Ningbo David Medical Device Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.29x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 37.47x to 3.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | CN¥0.38 | CN¥14.10 | x |
| 2009-12-31 | CN¥0.37 | CN¥14.10 | x |
| 2010-12-31 | CN¥0.51 | CN¥14.10 | x |
| 2011-12-31 | CN¥0.76 | CN¥14.10 | x |
| 2012-12-31 | CN¥2.23 | CN¥14.10 | x |
| 2013-12-31 | CN¥2.18 | CN¥14.10 | x |
| 2014-12-31 | CN¥2.37 | CN¥14.10 | x |
| 2015-12-31 | CN¥2.49 | CN¥14.10 | x |
| 2016-12-31 | CN¥2.65 | CN¥14.10 | x |
| 2017-12-31 | CN¥2.65 | CN¥14.10 | x |
| 2018-12-31 | CN¥2.75 | CN¥14.10 | x |
| 2019-12-31 | CN¥2.94 | CN¥14.10 | x |
| 2020-12-31 | CN¥3.29 | CN¥14.10 | x |
| 2021-12-31 | CN¥3.46 | CN¥14.10 | x |
| 2022-12-31 | CN¥3.70 | CN¥14.10 | x |
| 2023-12-31 | CN¥4.02 | CN¥14.10 | x |
| 2024-12-31 | CN¥4.08 | CN¥14.10 | x |
| 2025-12-31 | CN¥4.28 | CN¥14.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ningbo David Medical Device Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.06%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.91%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.21x
- Recent ROE (7.06%) is below the historical average (14.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 30.27% | 17.67% | 0.73x | 2.34x | CN¥16.61 Million |
| 2009 | 36.39% | 19.33% | 0.73x | 2.58x | CN¥21.00 Million |
| 2010 | 34.99% | 21.72% | 0.75x | 2.15x | CN¥27.56 Million |
| 2011 | 32.86% | 26.10% | 0.75x | 1.68x | CN¥37.54 Million |
| 2012 | 12.48% | 28.88% | 0.39x | 1.10x | CN¥14.66 Million |
| 2013 | 10.20% | 29.49% | 0.32x | 1.07x | CN¥1.26 Million |
| 2014 | 8.01% | 23.60% | 0.32x | 1.07x | CN¥-13.29 Million |
| 2015 | 6.44% | 20.48% | 0.29x | 1.08x | CN¥-24.86 Million |
| 2016 | 8.30% | 23.46% | 0.32x | 1.12x | CN¥-12.69 Million |
| 2017 | 6.04% | 15.48% | 0.35x | 1.11x | CN¥-30.80 Million |
| 2018 | 3.63% | 9.59% | 0.34x | 1.12x | CN¥-50.46 Million |
| 2019 | 7.49% | 17.41% | 0.37x | 1.16x | CN¥-20.83 Million |
| 2020 | 14.28% | 29.64% | 0.41x | 1.18x | CN¥40.84 Million |
| 2021 | 8.10% | 16.92% | 0.41x | 1.17x | CN¥-18.85 Million |
| 2022 | 9.19% | 19.24% | 0.40x | 1.18x | CN¥-8.57 Million |
| 2023 | 12.69% | 23.87% | 0.45x | 1.18x | CN¥31.26 Million |
| 2024 | 4.90% | 10.87% | 0.37x | 1.21x | CN¥-59.57 Million |
| 2025 | 7.06% | 14.91% | 0.39x | 1.21x | CN¥-36.24 Million |
Industry Comparison
This section compares Ningbo David Medical Device Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,751,772,335
- Average return on equity (ROE) among peers: 26.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ningbo David Medical Device Co Ltd (300314) | CN¥1.23 Billion | 30.27% | 0.19x | $594.22 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $1.27 Billion | 23.03% | 0.13x | $386.87 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $143.67 Million | 40.91% | 1.23x | $4.16 Billion |
| Double Medical Technology Inc (002901) | $3.69 Billion | 16.27% | 0.34x | $2.52 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $6.77 Billion | 62.15% | 0.36x | $491.32 Million |
| Lepu Medical Tech Beijing (300003) | $115.51 Million | 55.06% | 0.54x | $3.37 Billion |
| INKON Life Technology Co Ltd (300143) | $2.07 Billion | 2.43% | 0.27x | $821.42 Million |
| Edan Instruments Inc (300206) | $1.22 Billion | 8.49% | 0.19x | $1.01 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $46.53 Million | 22.70% | 0.68x | $503.27 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.09 Billion | 11.74% | 0.48x | $475.25 Million |
| Sinocare Inc (300298) | $1.11 Billion | 17.76% | 0.09x | $1.54 Billion |
About Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detector… Read more